Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRLM.L Regulatory News (RLM)

  • There is currently no data for RLM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

PuriCore Presenting at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference

25 Oct 2007 12:00

PuriCore (LSE:PURI), the life sciences company focused on thedevelopment and commercialization of its novel, safe antimicrobialtechnology, today announced that its Chief Executive Officer, GregBosch, will be presenting at the Acumen BioFin Rodman & Renshaw 9thAnnual Healthcare Conference at the New York Palace Hotel in New York,New York, on November 5, 2007. A live webcast of the presentation willbe available as of 4:05 p.m. EST on Monday, November 5, 2007, athttp://www.wsw.com/webcast/rrshq12/puri.ln. £ About PuriCore £ PuriCore (LSE:PURI) is a life sciences company focused ondeveloping and commercializing proprietary products that safely,effectively, and naturally kill contagious pathogens. PuriCore'stechnology provides a solution to a broad range of markets that dependupon controlling contamination, including food safety in retail andfoodservice, medical device disinfection, wound therapy, andhospitality. The Company's proprietary technology mimics the humanbody's production of the natural antimicrobial hypochlorous acid,which is highly effective in killing bacteria, viruses, and fungalspores. Deploying hypochlorous acid solutions as soaks, sprays, mists,and in other forms, PuriCore's technology is designed to limit thespread of infectious disease, including major public health threats ofM. tuberculosis, MRSA, E.coli, Norovirus, Avian Influenza, HIV, PolioVirus, Helicobater pylori, and Legionella. PuriCore is headquarteredin Malvern, Pennsylvania, with offices in Stafford, UK. £ To receive additional information on PuriCore, please visit ourwebsite at www.puricore.com, which does not form part of this pressrelease. £ Certain statements made in this announcement are forward-lookingstatements. These forward-looking statements are not historical factsbut rather are based on the Company's current expectations, estimates,and projections about its industry; its beliefs; and assumptions.Words such as 'anticipates,' 'expects,' 'intends,' 'plans,''believes,' 'seeks,' 'estimates,' and similar expressions are intendedto identify forward-looking statements. These statements are notguarantees of future performance and are subject to known and unknownrisks, uncertainties, and other factors, some of which are beyond theCompany's control, are difficult to predict, and could cause actualresults to differ materially from those expressed or forecasted in theforward-looking statements. The Company cautions shareholders andprospective shareholders not to place undue reliance on theseforward-looking statements, which reflect the view of the Company onlyas of the date of this announcement. The forward-looking statementsmade in this announcement relate only to events as of the date onwhich the statements are made. The Company will not undertake anyobligation to release publicly any revisions or updates to theseforward-looking statements to reflect events, circumstances, orunanticipated events occurring after the date of this announcementexcept as required by law or by any appropriate regulatory authority. Copyright Business Wire 2007
Date   Source Headline
1st Feb 20199:12 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
31st Jan 201910:06 amRNSForm 8.5 (EPT/RI) - Realm Therapeutics Plc
29th Jan 201910:19 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
25th Jan 20198:55 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
22nd Jan 20199:10 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
14th Jan 20199:44 amRNSForm 8.5 (EPT/RI) - Realm Therapeutics Plc
11th Jan 20199:39 amRNSForm 8.5 (EPT/RI) - Realm Therapeutics Plc
8th Jan 201910:41 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
4th Jan 20199:46 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
3rd Jan 20199:53 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
2nd Jan 20199:26 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
27th Dec 201810:47 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
24th Dec 201810:18 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
21st Dec 201810:26 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
20th Dec 201810:26 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
20th Dec 20188:54 amRNSForm 8.3 - Realm Therapeutics plc
19th Dec 201810:27 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
13th Dec 20189:35 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
10th Dec 20181:20 pmRNSForm 8.3 - Realm Therapeutics plc
10th Dec 201810:32 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
6th Dec 201810:46 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
5th Dec 20189:56 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
4th Dec 201812:20 pmRNSForm 8.5 (EPT/RI) Realm therapeutics
3rd Dec 201811:20 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
30th Nov 20184:08 pmRNSHolding(s) in Company
30th Nov 20181:18 pmRNSForm 8.3 - Realm Therapeutics plc
30th Nov 201811:39 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
29th Nov 201811:58 amRNSHolding(s) in Company
29th Nov 201811:13 amRNSForm 8.3 - Realm Therapeutics plc
29th Nov 20189:55 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
29th Nov 20187:00 amRNSUpdate on Strategic Review
28th Nov 201810:19 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
28th Nov 20189:53 amRNSForm 8.3 - Realm Therapeutics plc
27th Nov 20186:28 pmRNSForm 8.3 - Realm Therapeutics plc
26th Nov 201811:22 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
26th Nov 20188:41 amRNSForm 8.3 - Realm Therapeutics plc
12th Nov 20188:32 amRNSForm 8.5 (EPT/RI) Realm therapeutics
7th Nov 20185:14 pmRNSHolding(s) in Company
7th Nov 201810:37 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
7th Nov 20189:03 amRNSForm 8.3 - Realm Therapeutics plc
6th Nov 201810:36 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
2nd Nov 201811:31 amRNSForm 8.3 - Realm Therapeutics plc
31st Oct 20189:04 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
25th Oct 20189:34 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
19th Oct 201810:23 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
17th Oct 201810:37 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
16th Oct 20189:31 amRNSForm 8.5 (EPT/RI) Realm therapeutics
15th Oct 20189:34 amRNSForm 8.3 - Realm Therapeutics plc
15th Oct 20189:24 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
12th Oct 20188:58 amRNSForm 8.5 (EPT/RI) Realm Therapeutics

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.